Clinical Trials Directory

Trials / Completed

CompletedNCT05220540

Retrospective Analysis of Balloon Expandable Covered Stenting in the Common Femoral Artery

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Semmelweis University Heart and Vascular Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the safety and efficacy of balloon expandable covered stenting of access complications, stenoses or pseudoaneurysms of the common femoral access.

Detailed description

In the past decades, there has been a paradigm shift in the field of vascular surgery, with endovascular interventions replacing traditional open surgical procedures on an increasing scale. Most of these interventions are performed via the femoral artery. Even with modern percutaneous vascular closure devices, interventional laboratories report a high incidence of vascular complications, most commonly bleeding. Interventional procedures are gaining ground as an alternative to surgery. Having regard to the fact that femoral arteries are in constant motion due to their location and are subject to intense bending forces, the long-term durability of stents has been questioned in the absence of long-term follow-up data. There is currently no broad consensus on the strategy of care for vascular complications, and overall the decision is left to the discretion of the interventionalist, largely determined by the available local resources and infrastructure. The use of covered stents is an option for endovascular treatment of the complications: the self expanding nitinol framed stent graft with polytetrafluoroethylene (PTFE) coating and the cobalt-chrome framed, also PTFE coated balloon expandable stent. The main aim of this research is to analyse the short- and long-term outcome of these alternatives.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2023-08-10
Completion
2023-08-31
First posted
2022-02-02
Last updated
2023-11-21

Locations

3 sites across 1 country: Hungary

Source: ClinicalTrials.gov record NCT05220540. Inclusion in this directory is not an endorsement.